Learn more about NAMS: http://www.menopause.org/home
New and promising GSM treatments, more clinical takeaways from NAMS 2018
Dr. Richard-Davis is Professor, Obstetrics and Gynecology, and Division Director, Reproductive Endocrinology and Infertility at the University of Arkansas for Medical Sciences, Little Rock, Arkansas.
The author reports no financial relationships related to this audio.
Dr. Richard-Davis served as the Scientific Program Chair of the 2018 North American Menopause Society (NAMS) Meeting. In this audiocast she highlights several clinical takeaways from the meeting, including:
- new treatments for uterine fibroids
- the telomere’s role in helping women live longer lives, and protective (estrogen) and adverse (stress, obesity) factors affecting telomere length that patients can address through a healthy lifestyle
- the legal risks of not screening for hereditary cancer
- obesity prevention, treatment, and long-term lifestyle changes during menopause
- new and on-the-horizon therapies for GSM
- much more.